Funding for this research was provided by:
Agency for Healthcare Research and Quality (R21HS025005)
National Institutes of Health (TL1TR001107)
Received: 13 February 2019
Accepted: 4 July 2019
First Online: 16 July 2019
Ethics approval and consent to participate
: This evaluation was approved by the Purdue University Institutional Review Board (IRB; study number 1608018057.) Pharmacists provided written informed consent; patient consent was waived by the IRB.
: Not applicable.
: Dr. Snyder reports that she serves as a consultant to Westat, Inc. on an evaluation of the Centers for Medicare and Medicaid Services’ Enhanced MTM program. Ms. Militello reports that she is co-owner of Applied Decision Science, LLC. All other authors report that they have no conflicts of interest.